CSPC Pharmaceutical Group Ltd

01093

Company Profile

  • Business description

    CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.

  • Contact

    No.896 Zhongshandong Street
    Gaoxin District
    Hebei Province
    Shijiazhuang050035
    CHN

    T: +86 31187037015

    https://www.cspc.com.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2026

    Employees

    19,700

Stocks News & Analysis

stocks

Cheap ASX share may have more room to run

Shares are cheap despite rebounding share price, yet risks remain.
stocks

ASX listed media giant drives strong earnings growth

Digital growth drives earnings beat for media share.
stocks

ASX real estate platform outperforms yet questions remain

Valuation remains a key concern despite strong August reporting.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,424.1013.30-0.14%
CAC 408,715.320.390.00%
DAX 4026,357.5738.120.14%
Dow JONES (US)54,036.93151.830.28%
FTSE 10010,886.6814.41-0.13%
HKSE25,902.16234.130.91%
NASDAQ26,690.62342.261.30%
Nikkei 22566,970.221,363.512.08%
NZX 50 Index13,888.2464.110.46%
S&P 5007,757.6447.680.62%
S&P/ASX 2009,232.6017.00-0.18%
SSE Composite Index3,966.5926.560.67%

Market Movers